KRAS and neoplasm: Although numerous advances in understanding the molecular biology of pancreatic cancer and in diagnosis and treatment regarding KRAS mutations, tumor metabolism, and tumor immunology have been made, minimal progress has been achieved in improving the survival of patients [3,4].